EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Pharmacokinetic evaluation of paclitaxel, albumin-binding paclitaxel, and liposomal-encapsulated albumin-binding paclitaxel upon gastric subserosal administration

Yoontaek Lee, Sun Mi Park, In Ho Song, Bom Sahn Kim, Hyun Soo Park, Byung Seok Moon, Hyung-Ho Kim

Frontiers in Pharmacology · 06.06.2024 · 15

DOI: 10.3389/fphar.2024.1381406 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 06.06.2024. Verfasst von Yoontaek Lee und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Ewha Womans University Seoul Hospital, Ewha Womans University College of Medicine, Seoul, Republic of Korea. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea, Korean Gastric Cancer Association.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Systemic chemotherapy is typically administered following radical gastrectomy for advanced stage. To attenuate systemic side effects, we evaluated the effectiveness of regional chemotherapy using paclitaxel, albumin-paclitaxel, and liposome-encapsulated albumin-paclitaxel via subserosal injection in rat models employing nuclear medicine and molecular imaging technology.

Method

Nine Sprague Dawley rats were divided into three groups: paclitaxel ( n = 3), albumin-paclitaxel nano-particles (APNs; n = 3), and liposome-encapsulated APNs ( n = 3). [ 123 I]Iodo-paclitaxel ([ 123 I]I-paclitaxel) was synthesized by conventional electrophilic radioiodination using tert -butylstannyl substituted paclitaxel as the precursor. Albumin-[ 123 I]iodo-paclitaxel nanoparticles ([ 123 I]APNs) were prepared using a desolvation technique. Liposome-encapsulated APNs (L-[ 123 I]APNs) were prepared by thin-film hydration using DSPE-PEG2000, HSPC, and cholesterol. The rats in each group were injected with each test drug into the subserosa of the stomach antrum. After predetermined times (30 min, 2, 4, 8 h, and 24 h), molecular images of nuclear medicine were acquired using single-photon emission computed tomography/computed tomography.

Results

Paclitaxel, APNs, and L-APNs showed a high cumulative distribution in the stomach, with L-APNs showing the largest area under the curve. Most drugs administered via the gastric subserosal route are distributed in the stomach and intestines, with a low uptake of less than 1% in other major organs. The time to reach the maximum concentration in the intestine for L-APNs, paclitaxel, and APNs was 6.67, 5.33, and 4.00 h, respectively.

Conclusion

These preliminary results imply that L-APNs have the potential to serve as a novel paclitaxel preparation method for the regional treatment of gastric cancer.

Schlagwörter

Stichwörter der Autor:innen

anticancergastric subserosal administrationliposome-encapsulated albumin-paclitaxel nanoparticlesnuclear medicine and molecular imagingpaclitaxel

Autor:innen und Institutionen

  • Department of Surgery, Ewha Womans University Seoul Hospital, Ewha Womans University College of Medicine, Seoul, Republic of Korea.
  • Department of Nuclear Medicine, Ewha Womans University Seoul Hospital, Ewha Womans University College of Medicine, Seoul, Republic of Korea.
  • Department of Nuclear Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Republic of Korea.
  • Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University, Seoul, Republic of Korea.
  • molim, Inc., Suwon, Republic of Korea.
  • Department of Surgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Republic of Korea.

Förderung

  • National Research Foundation of Korea
  • Korean Gastric Cancer Association

Zitieren

APA

Lee, Y., Park, S. M., Song, I. H., Kim, B. S., Park, H. S., Moon, B. S., & Kim, H. H. (2024). Pharmacokinetic evaluation of paclitaxel, albumin-binding paclitaxel, and liposomal-encapsulated albumin-binding paclitaxel upon gastric subserosal administration. Frontiers in Pharmacology, 15. https://doi.org/10.3389/fphar.2024.1381406

Vancouver

Lee Y, Park SM, Song IH, Kim BS, Park HS, Moon BS, et al. Pharmacokinetic evaluation of paclitaxel, albumin-binding paclitaxel, and liposomal-encapsulated albumin-binding paclitaxel upon gastric subserosal administration. Frontiers in Pharmacology. 2024;15. doi:10.3389/fphar.2024.1381406

BibTeX
@article{Lee2024,
  author = {Lee, Yoontaek and Park, Sun Mi and Song, In Ho and Kim, Bom Sahn and Park, Hyun Soo and Moon, Byung Seok and Kim, Hyung-Ho},
  title = {Pharmacokinetic evaluation of paclitaxel, albumin-binding paclitaxel, and liposomal-encapsulated albumin-binding paclitaxel upon gastric subserosal administration},
  journal = {Frontiers in Pharmacology},
  year = {2024},
  volume = {15},
  doi = {10.3389/fphar.2024.1381406}
}
Kostenlos starten →